{"entity":{"id":"nct07656766","kind":"trial","name":"Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer","aka":[],"tldr":"A phase 2 trial of sintilimab in colorectal cancer, run by Peking University People's Hospital, not yet recruiting.","summary":"Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer is a phase 2, interventional study registered as NCT07656766 by Peking University People's Hospital, with a registry enrolment figure of 32 participants, started 2026-07-15 and due to reach its primary completion in 2027-09-15. Interventions recorded: Sintilimab; Gossypol Acetate. Conditions listed: Advanced Colorectal Cancer. Primary outcome: Objective Response Rate. Colorectal eligibility wording from the registry: \"Histologically or cytologically confirmed advanced colorectal adenocarcinoma\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07656766","url":"https://clinicaltrials.gov/study/NCT07656766"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":["checkpoint-inhibitor"],"targets":[],"drugs":["sintilimab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07656766","phase":"2","setting":"A Single-Arm, Open-Label, Exploratory Phase II Clinical Trial of Sintilimab Plus Gossypol Acetate in Patients With Advanced pMMR/MSS Colorectal Cancer After Failure of at Least Two Prior Lines of Therapy","sponsor":"Peking University People's Hospital","enrolled":32,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07656766/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"checkpoint-inhibitor","kind":"technology","name":"Immune checkpoint inhibitors","route":"/technologies/checkpoint-inhibitor/"}],"drug":[{"id":"sintilimab","kind":"drug","name":"Sintilimab","route":"/drugs/sintilimab/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}